Federal
Register Notices > Manufacturers 2008
>
Austin Pharma, LLC
FR Doc E8-18046[Federal Register: August 6, 2008 (Volume 73, Number 152)]
[Notices] [Page 45785] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-96]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is
notice that on May 23, 2008, Austin Pharma, LLC., 811 Paloma Drive, Suite A,
Round Rock, Texas 78665-2402, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
Drug
|
Schedule
|
Marihuana (7360)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Alphamethadol (9605)
|
I
|
Nabilone (7379)
|
II
|
Methadone (9250)
|
II
|
Methadone Intermediate (9254)
|
II
|
Levo-alphacetylmethadol (9648)
|
II
|
Alfentanil (9737)
|
II
|
Remifentanil (9739)
|
II
|
Sufentanil (9740)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic intermediate. This controlled substance
will be further synthesized to bulk manufacture a synthetic THC (7370). No other
activity for this drug code is authorized for this registration.
Any other such applicant, and any person who is presently, registered with
DEA to manufacture such substances may file comments or objections to the
issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in quintuplicate,
to the Drug Enforcement Administration, Office of Diversion Control, Federal
Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia
22152; and must be filed no later than October 6, 2008.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator/Deputy Chief of Operation, Office of
Diversion Control, Drug Enforcement Administration.
[FR Doc. E8-18046 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|